European Medicines Agency

Latest Stories

This Wednesday, Oct. 7, 2020 file photo shows a vial of the Phase 3 Novavax coronavirus vaccine ready for use in a trial at St. George's University hospital in London. The global health agency added Nuvaxovid, also known as NVX-CoV2373, to its emergency use listing following an approval from the European Medicines Agency (EMA). (AP Photo/Alastair Grant, File)

WHO authorizes tenth COVID-19 vaccine, developed by Maryland-based biotech company Novavax

By Shen Wu Tan - The Washington Times

FILE - This undated file image provided by Merck &amp; Co. shows their new antiviral medication. The European Medicines Agency said it has received a request from Merck to authorize its coronavirus antiviral, the first pill shown to treat COVID-19. In a statement on Tuesday, Nov. 23, 2021, the EU drug regulator said it had started evaluating molnupiravir, made by Merck and Ridgeback Biotherapeutics and that a decision could be made within weeks on whether it might be cleared. (Merck &amp; Co. via AP, File)

Merck asks EU regulator to authorize its COVID-19 pill

Associated Press

FILE - In this Feb. 19, 2021 file photo, a doctor prepares a dose of the Sputnik V COVID-19 vaccine at the Ana Francisca Perez de Leon II public hospital, in Caracas, Venezuela. Brazil's health regulator rejected on Monday, April 19, 2021, a request from several states to import almost 30 million doses of the Sputnik V vaccine, citing safety concerns, prompting criticism from the Russian government. (AP Photo/Matias Delacroix, File)

EU report takes aim at Russia over vaccine fake news

By LORNE COOK - Associated Press

Belgium imposes ban on AZ jabs for people under 56

Associated Press

This Sunday, March 21, 2021, file photo shows a vial of the AstraZeneca COVID-19 vaccine at the Guru Nanak Gurdwara Sikh temple, on the day the first Vaisakhi Vaccine Clinic is launched, in Luton, England. A top official at the European Medicines Agency says there's a causal link between the AstraZeneca coronavirus vaccine and rare cases of blood clots, but he says the benefits of getting the vaccine still outweigh the risks, it was reported on Tuesday, April 6, 2021. (AP Photo/Alberto Pezzali, File)

EU drug regulator: Rare clots possibly linked to AstraZeneca shot

By Maria Cheng - Associated Press

The doctor Wolfgang Ritter vaccinates the couple Edith and Erich Dengler at the start of the Corona vaccinations in Bavarian GP practices in Munich, Germany, Wednesday, March 31, 2021. Vaccinated was the vaccine from Astrazeneca. (Peter Kneffel/dpa via AP)

EU says ‘no evidence’ to restrict use of AstraZeneca vaccine

By FRANK JORDANS - Associated Press

FILE - In this March 12, 2021, file photo, a health worker holds a bottle of AstraZeneca COVID-19 vaccine with name Thailand's Prime Minister Prayuth Chan-ocha written on it, at Bamrasnaradura Hospital in Bangkok, Thailand. In recent days, countries including Denmark, Ireland and Thailand have temporarily suspended their use of AstraZeneca's coronavirus vaccine after reports that some people who got a dose developed blood clots, even though there's no evidence that the shot was responsible. The European Medicines Agency and the World Health Organization say the data available do not suggest the vaccine caused the clots. (AP Photo/Sakchai Lalit, File)

EXPLAINER: Why countries are halting the AstraZeneca shot

By MARIA CHENG - Associated Press

A health worker administers a dose of the AstraZeneca vaccine against COVID-19 to a patient inside the convention center known as &quot;La Nuvola&quot;, The Cloud, in Rome, Wednesday, March 10, 2021. The visually extraordinary complex designed by famed architect Massimiliano Fuksas has been transformed into a temporary vaccination center. (AP Photo/Andrew Medichini)

Germany, others stick with AstraZeneca vaccine as some pause

By FRANK JORDANS - Associated Press

European Medicines Agency recommends that Johnson & Johnson’s one-dose coronavirus vaccine be licens

Associated Press

An ampoule Moderna vaccine against the COVID-19 disease, stand on the table at the Diakonie Hospital &quot;DIAKO&quot; vaccination ward in Bremen, Germany, Friday, Jan. 15, 2021. Besides the Pfizer/BioNTech vaccine, Moderna is the second corona vaccine approved in the European Union. (Mohssen Assanimoghaddam/dpa via AP)

EU regulator: Hackers ‘manipulated’ stolen vaccine documents

By MARIA CHENG - Associated Press

A healthcare worker fills a syringe with the Oxford/AstraZeneca Covid-19 vaccine at the vaccine centre that has been set up in central Newcastle, Scotland Monday Jan. 11, 2021. The centre is one of the seven mass vaccination centres that opened Monday as the government continues to ramp up the coronavirus vaccination programme. (Owen Humphreys/PA via AP)

EU regulator is considering Oxford-AstraZeneca vaccine

Associated Press

A person enters the European Medicines Agency in Amsterdam, Netherlands, Monday, Dec. 21, 2020, where the EMA's human medicines committee is holding an exceptional, fully virtual, meeting to conclude the evaluation of the Pfizer-BioNTech COVID-19 vaccine. (AP Photo/Peter Dejong)

EU greenlights COVID-19 vaccine after agency gives safety OK

By FRANK JORDANS and LORNE COOK - Associated Press

FILE - In this Tuesday, Dec. 8, 2020 file photo, a nurse holds a phial of the Pfizer-BioNTech COVID-19 vaccine at Guy's Hospital in London. As Canadians, Britons and Americans begin getting immunized with a German-developed vaccine against the coronavirus, pressure is building on the European Medicines Agency to approve the shot made by Pfizer Inc. and German company BioNTech. Those countries all approved the COVID-19 vaccine under emergency use rules, meaning it is an unlicensed product. But the EMA approval process for coronavirus vaccines is largely similar to the standard licensing procedure that would be granted to any new vaccine, only on an accelerated schedule. (AP Photo/Frank Augstein, Pool, File)

EXPLAINER: Why is the EU taking so long to OK vaccine?

Associated Press

A nurse prepares a shot of the Pfizer-BioNTech COVID-19 vaccine at Guy's Hospital in London, Tuesday, Dec. 8, 2020, as the U.K. health authorities rolled out a national mass vaccination program. (AP Photo/Frank Augstein, Pool)

BioNTech, coronavirus vaccine maker, says regulatory documents unlawfully accessed in cyberattack

By Andrew Blake - The Washington Times

Emer Cooke, the head of the European Medicines Agency, at the European Medicines Agency building in Amsterdam, the Netherlands, Friday Nov. 13, 2020. Emer Cooke, the executive director of the European Medicines Agency said Tuesday she hopes there might be “multiple&quot; vaccines to help stop the coronavirus pandemic by the end of next year. (European Medicine Agency via AP)

AP Interview: EU regulator hopes for ‘multiple’ vaccines

By MARIA CHENG - Associated Press

This May 4, 2020, file photo provided by the University of Maryland School of Medicine, shows the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore. The German pharmaceutical company BioNTech and its U.S. partner Pfizer say they have submitted an application for conditional approval of their coronavirus vaccine with the European Medicines Agency. (Courtesy of University of Maryland School of Medicine via AP, File)

BioNTech, Pfizer ask Europe to OK vaccine for emergency use

By Frank Jordans - Associated Press

FILE - This April 30, 2020, file photo shows Gilead Sciences headquarters in Foster City, Calif. The European Medicines Agency says it has started a safety review after some patients taking the coronavirus drug remdesivir reported serious kidney problems. In a statement on Friday, Oct. 2, 2020, the EU regulator said it isn’t clear whether remdesivir is causing the “acute kidney injury,” but that the issue “warrants further investigation.” Remdesivir is one of the few licensed treatments for the coronavirus, in additional to the generic steroid dexamethasone. In July, health experts criticized the U.S. for buying up a significant portion of the drug, made by Gilead Sciences. (AP Photo/Ben Margot, File)

EU regulator starts safety review of coronavirus drug

Associated Press

FILE - In this Monday, March 30, 2020 file photo, a black crow flies over in the deserted Louvre museum courtyard in Paris. The European Union unveiled Wednesday May 13, 2020, its plan to help confinement-tortured citizens across the 27 nations salvage their summer vacations after months of coronavirus lockdown and resurrect Europe’s badly battered tourism industry. (AP Photo/Francois Mori, File)

EU health agency ‘optimistic’ coronavirus vaccine could be available by 2021

By Lauren Toms - The Washington Times

EU: Malaria drugs used for virus could cause side effects

Associated Press

EU drug agency urges approval for dengue vaccine

Associated Press